Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1997 1
1999 2
2000 1
2003 1
2004 3
2005 2
2006 1
2007 2
2008 3
2009 3
2010 2
2011 3
2012 3
2013 3
2014 2
2015 4
2016 9
2017 5
2018 2
2019 4
2020 2
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.
Cao J, Choi M, Guadagnin E, Soty M, Silva M, Verzieux V, Weisser E, Markel A, Zhuo J, Liang S, Yin L, Frassetto A, Graham AR, Burke K, Ketova T, Mihai C, Zalinger Z, Levy B, Besin G, Wolfrom M, Tran B, Tunkey C, Owen E, Sarkis J, Dousis A, Presnyak V, Pepin C, Zheng W, Ci L, Hard M, Miracco E, Rice L, Nguyen V, Zimmer M, Rajarajacholan U, Finn PF, Mithieux G, Rajas F, Martini PGV, Giangrande PH. Cao J, et al. Among authors: giangrande ph. Nat Commun. 2021 May 25;12(1):3090. doi: 10.1038/s41467-021-23318-2. Nat Commun. 2021. PMID: 34035281 Free PMC article.
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3.
Wei G, Cao J, Huang P, An P, Badlani D, Vaid KA, Zhao S, Wang DQ, Zhuo J, Yin L, Frassetto A, Markel A, Presnyak V, Gandham S, Hua S, Lukacs C, Finn PF, Giangrande PH, Martini PGV, Popov YV. Wei G, et al. Among authors: giangrande ph. J Hepatol. 2021 Jun;74(6):1416-1428. doi: 10.1016/j.jhep.2020.12.010. Epub 2020 Dec 17. J Hepatol. 2021. PMID: 33340584 Free PMC article.
Advances in mRNA non-viral delivery approaches.
Ibba ML, Ciccone G, Esposito CL, Catuogno S, Giangrande PH. Ibba ML, et al. Among authors: giangrande ph. Adv Drug Deliv Rev. 2021 Oct;177:113930. doi: 10.1016/j.addr.2021.113930. Epub 2021 Aug 14. Adv Drug Deliv Rev. 2021. PMID: 34403751 Review.
Aptamers: Cutting edge of cancer therapies.
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Shigdar S, et al. Among authors: giangrande ph. Mol Ther. 2021 Aug 4;29(8):2396-2411. doi: 10.1016/j.ymthe.2021.06.010. Epub 2021 Jun 17. Mol Ther. 2021. PMID: 34146729 Review.
Aptamers as Diagnostic Tools in Cancer.
Ruiz Ciancio D, Vargas MR, Thiel WH, Bruno MA, Giangrande PH, Mestre MB. Ruiz Ciancio D, et al. Among authors: giangrande ph. Pharmaceuticals (Basel). 2018 Sep 11;11(3):86. doi: 10.3390/ph11030086. Pharmaceuticals (Basel). 2018. PMID: 30208607 Free PMC article. Review.
Cell-specific aptamers for targeted therapies.
Cerchia L, Giangrande PH, McNamara JO, de Franciscis V. Cerchia L, et al. Among authors: giangrande ph. Methods Mol Biol. 2009;535:59-78. doi: 10.1007/978-1-59745-557-2_5. Methods Mol Biol. 2009. PMID: 19377980 Free PMC article. Review.
Aptamers in Bordeaux, 24-25 June 2016.
Toulmé JJ, Giangrande PH, Mayer G, Suess B, Ducongé F, Sullenger B, de Franciscis V, Darfeuille F, Peyrin E. Toulmé JJ, et al. Among authors: giangrande ph. Pharmaceuticals (Basel). 2017 Jan 20;10(1):14. doi: 10.3390/ph10010014. Pharmaceuticals (Basel). 2017. PMID: 28117671 Free PMC article.
60 results